Adams, Lynn S <br/><br/>
Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway.  [electronic resource] 

 -  Cancer research  May 2010 
 - 3594-605 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-09-3565  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Beverages<br/>Blueberry Plants<br/>Breast Neoplasms--drug therapy<br/>Cell Growth Processes--drug effects<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Female<br/>Flavonoids--analysis<br/>Fruit--chemistry<br/>Humans<br/>Matrix Metalloproteinase 2--metabolism<br/>Matrix Metalloproteinase 9--metabolism<br/>Matrix Metalloproteinase Inhibitors<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Phenols--analysis<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Plant Extracts--analysis<br/>Plasminogen Activator Inhibitor 1--metabolism<br/>Polyphenols<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Signal Transduction--drug effects<br/>Tissue Inhibitor of Metalloproteinase-1--metabolism<br/>Urokinase-Type Plasminogen Activator--metabolism<br/>Xenograft Model Antitumor Assays